These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32930885)

  • 41. Complications of the nevoid basal cell carcinoma syndrome: a case report.
    Walter AW; Pivnick EK; Bale AE; Kun LE
    J Pediatr Hematol Oncol; 1997; 19(3):258-62. PubMed ID: 9201152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.
    Susanto E; Marin Navarro A; Zhou L; Sundström A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Hübner JM; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjö P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20127-20138. PubMed ID: 32747535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).
    Guerrini-Rousseau L; Smith MJ; Kratz CP; Doergeloh B; Hirsch S; Hopman SMJ; Jorgensen M; Kuhlen M; Michaeli O; Milde T; Ridola V; Russo A; Salvador H; Waespe N; Claret B; Brugieres L; Evans DG
    Fam Cancer; 2021 Oct; 20(4):317-325. PubMed ID: 33860896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
    Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
    Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
    J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ex vivo miRNome analysis in Ptch1+/- cerebellum granule cells reveals a subset of miRNAs involved in radiation-induced medulloblastoma.
    Tanno B; Babini G; Leonardi S; Giardullo P; De Stefano I; Pasquali E; Ottolenghi A; Atkinson MJ; Saran A; Mancuso M
    Oncotarget; 2016 Oct; 7(42):68253-68269. PubMed ID: 27626168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
    Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O
    J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161.
    Smith MJ; Woodward ER; Evans DG
    Fam Cancer; 2023 Jul; 22(3):341-344. PubMed ID: 36961676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medulloblastoma in a toddler with Gorlin syndrome.
    Al-Rahawan MG; Trevino S; Jacob R; Murray JC; Al-Rahawan MM
    Proc (Bayl Univ Med Cent); 2018 Apr; 31(2):216-218. PubMed ID: 29706825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Case of Gorlin-Goltz Syndrome Without the Characteristic Physical Features That Was Diagnosed After the Development of a Fifth Cancer.
    Katayama D; Inoue A; Kayatani R; Urabe K; Suzuki R; Takitani K; Yoshida M; Kato M; Ashida A
    J Pediatr Hematol Oncol; 2022 May; 44(4):e869-e871. PubMed ID: 35235545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis.
    Lou E; Nelson AC; Kool M
    Cancer Biol Ther; 2019; 20(11):1398-1402. PubMed ID: 31423907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.
    Yin WC; Satkunendran T; Mo R; Morrissy S; Zhang X; Huang ES; Uusküla-Reimand L; Hou H; Son JE; Liu W; Liu YC; Zhang J; Parker J; Wang X; Farooq H; Selvadurai H; Chen X; Ngan ES; Cheng SY; Dirks PB; Angers S; Wilson MD; Taylor MD; Hui CC
    Dev Cell; 2019 Jan; 48(2):167-183.e5. PubMed ID: 30554998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular basis of Turcot's syndrome.
    Hamilton SR; Liu B; Parsons RE; Papadopoulos N; Jen J; Powell SM; Krush AJ; Berk T; Cohen Z; Tetu B
    N Engl J Med; 1995 Mar; 332(13):839-47. PubMed ID: 7661930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
    Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
    Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.
    Tan IL; Wojcinski A; Rallapalli H; Lao Z; Sanghrajka RM; Stephen D; Volkova E; Korshunov A; Remke M; Taylor MD; Turnbull DH; Joyner AL
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3392-3397. PubMed ID: 29531057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1
    Di Pietro C; La Sala G; Matteoni R; Marazziti D; Tocchini-Valentini GP
    Exp Neurol; 2019 Feb; 312():33-42. PubMed ID: 30452905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
    Cambruzzi E
    Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.
    Huq AJ; Walsh M; Rajagopalan B; Finlay M; Trainer AH; Bonnet F; Sevenet N; Winship IM
    Fam Cancer; 2018 Oct; 17(4):601-606. PubMed ID: 29356994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.
    Suzuki H; Kumar SA; Shuai S; Diaz-Navarro A; Gutierrez-Fernandez A; De Antonellis P; Cavalli FMG; Juraschka K; Farooq H; Shibahara I; Vladoiu MC; Zhang J; Abeysundara N; Przelicki D; Skowron P; Gauer N; Luu B; Daniels C; Wu X; Forget A; Momin A; Wang J; Dong W; Kim SK; Grajkowska WA; Jouvet A; Fèvre-Montange M; Garrè ML; Nageswara Rao AA; Giannini C; Kros JM; French PJ; Jabado N; Ng HK; Poon WS; Eberhart CG; Pollack IF; Olson JM; Weiss WA; Kumabe T; López-Aguilar E; Lach B; Massimino M; Van Meir EG; Rubin JB; Vibhakar R; Chambless LB; Kijima N; Klekner A; Bognár L; Chan JA; Faria CC; Ragoussis J; Pfister SM; Goldenberg A; Wechsler-Reya RJ; Bailey SD; Garzia L; Morrissy AS; Marra MA; Huang X; Malkin D; Ayrault O; Ramaswamy V; Puente XS; Calarco JA; Stein L; Taylor MD
    Nature; 2019 Oct; 574(7780):707-711. PubMed ID: 31664194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Kimura H; Stephen D; Joyner A; Curran T
    Oncogene; 2005 Jun; 24(25):4026-36. PubMed ID: 15806168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.